News

Home / News
Milla Pharmaceuticals Announces Approval of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers.

Milla Pharmaceuticals Announces Approval of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers.

Milla Pharmaceuticals, a subsidiary of the Alter Pharma Group, announced that it has received abbreviated new drug application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its generic version of Magnesium Sulfate in Water for Injection, 2 g/50 mL (40 mg/mL), 4 g/100 mL (40 mg/mL), and 4 g/50 mL (80 mg/mL), in Non-PVC, Single-Patient Use Containers (Magnesium Sulfate Injection). Magnesium Sulfate Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously, it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous...

Read More
Milla Pharmaceuticals Announces Approval and Launch of a Generic Version of Sodium Acetate Injection 2MEQ/mL by Pfizer Inc.

Milla Pharmaceuticals Announces Approval and Launch of a Generic Version of Sodium Acetate Injection 2MEQ/mL by Pfizer Inc.

– Company granted 180-days of exclusivity under FDA Competitive Generic Therapy approval pathway – Milla Pharmaceuticals, a subsidiary of the Alter Pharma Group, announced that it has received abbreviated new drug application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its generic version of Sodium Acetate Injection 2MEQ/mL. Milla Pharmaceuticals was previously granted a Competitive Generic Therapy (CGT) designation for its generic drug by the FDA, which is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also...

Read More
First Alter Pharma product hits the US market: Sandoz launches generic injectable acetaminophen developed by Milla Pharmaceuticals

First Alter Pharma product hits the US market: Sandoz launches generic injectable acetaminophen developed by Milla Pharmaceuticals

Sandoz generic injectable acetaminophen, developed by Milla Pharmaceuticals, immediately available to US patients upon launch On 8 December 2020, Sandoz announced the US launch of its generic injectable acetaminophen (paracetamol IV), available as 100 mL glass vial containing 1,000 mg acetaminophen (10 mg/mL). The generic drug is used in adult and pediatric patients of two years and older to relieve mild to moderate pain and to treat moderate to severe pain in conjunction with opioid analgesics. It can also be used to reduce fever. “At Sandoz, we are continuously growing our injectable medicines portfolio to ensure patients across the US...

Read More